O14744 (ANM5_HUMAN) Homo sapiens (Human)

Protein arginine N-methyltransferase 5 UniProtKBInterProSTRINGInteractive Modelling

637 aa; Sequence (Fasta) ; (Isoform 2; Isoform 4; Isoform 5; Isoform 3); 7 identical sequences: Pan troglodytes: K7B5I7; Gorilla gorilla gorilla: G3R5J7; Papio anubis: A0A096N5H2; Macaca mulatta: H9FNP7; Macaca fascicularis: G8F670; Rhinopithecus roxellana: A0A2K6NY20; Carlito syrichta: A0A1U7TTX7

Available Structures

25 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
PRMT5 complex bound to covalent PBM inhibitor BRD6711 Heteromer
Q9BQA1;
QN4;CL;SFG;GOL;13-637
Assess
Crystal Structure of the human PRMT5:MEP50 Complex Heteromer
P62805; Q9BQA1;
0XU;13-637
Assess
CRYSTAL STRUCTURE OF THE HUMAN PRMT5:MEP50 COMPLEX with JNJ44064146 Heteromer
Q9BQA1;
K8H;13-637
Assess
Crystal structure of PRMT5:MEP50 with Compound 8 and sinefungin Heteromer
Q9BQA1;
SFG;5QJ; 16×GOL;13-637
Assess
Crystal Structure of PRMT5:MEP50 in complex with MTA and H4 peptide Heteromer
P62805; Q9BQA1;
MTA;13-637
Assess
Crystal structure of PRMT5:MEP50 with EPZ015666 and sinefungin Heteromer
Q9BQA1;
SFG;3XV;GOL;13-637
Assess
Crystal structure of PRMT5:MEP50 with EPZ015866 and sinefungin Heteromer
Q9BQA1;
SFG;4Z2;GOL;13-637
Assess
Crystal structure of PRMT5:MEP50 with Compound 15 and sinefungin Heteromer
Q9BQA1;
SFG;5QL;GOL;13-637
Assess
Crystal structure of PRMT5:MEP50 with Compound 10 and SAM Heteromer
Q9BQA1;
SAM;5QK;GOL;13-637
Assess
PRMT5:MEP50 Complexed with 5,5-Bicyclic Inhibitor Compound 34 Heteromer
Q9BQA1;
EDO;WFS;13-637
Assess
PRMT5-MEP50 Complexed with SAM Heteromer
Q9BQA1;
15×EDO;CL;SAM;13-637
Assess
PRMT5:MEP50 Complexed with 5,5-Bicyclic Inhibitor Compound 72 Heteromer
Q9BQA1;
EDO;WFV;13-637
Assess
Crystal structure of PRMT5:MEP50 with Compound 9 and sinefungin Heteromer
Q9BQA1;
SFG;5QH;GOL;13-637
Assess
PRMT5:MEP50 Complexed with 5,5-Bicyclic Inhibitor Compound 4 Heteromer
Q9BQA1;
WFM; 10×EDO;CL;PEG;13-637
Assess
CRYSTAL STRUCTURE OF THE HUMAN PRMT5:MEP50 COMPLEX with JNJ45031882 Heteromer
Q9BQA1;
K8N;13-637
Assess
PRMT5:MEP50 Complexed with Allosteric Inhibitor Compound 8 Heteromer
Q9BQA1;
QKY;EDO;GOL;13-637
Assess
Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase (PRMT5) Inhibitors Heteromer
Q9BQA1;
CUX;DMS;EDO;13-637
Assess
Structure of PRMT5:MEP50 in complex with LLY-283, a potent and selective inhibitor of PRMT5, with a… Heteromer
Q9BQA1;
F5J;13-637
Assess
Crystal structure of PRMT5:MEP50 with EPZ015666 and SAM Heteromer
Q9BQA1;
SAM;3XV;GOL;13-637
Assess
PRMT5 bound to the PBM peptide from pICln Heteromer
P54105; Q9BQA1;
SFG;ACE;13-637
Assess
Crystal structure of PRMT5:MEP50 with EPZ015666 and SAH Heteromer
Q9BQA1;
SAH;3XV;13-637
Assess
CryoEM structure of PRMT5 bound to covalent PBM-site inhibitor BRD-6988 Heteromer
Q9BQA1;
YJG;13-637
Assess
Cryo-EM structure of the apo form of human PRMT5:MEP50 complex at a resolution of 3.4 angstrom Heteromer
Q9BQA1;
13-637
Assess
PRMT5 bound to PBM peptide from Riok1 Heteromer
Q9BQA1; Q9BRS2;
SFG;14-637
Assess
PRMT5:MEP50 Complexed with Allosteric Inhibitor Compound 1a Heteromer
Q9BQA1;
QL1;14-637
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer0.925fa5.1.A13-637
100.00
Assess

4 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2monomer0.925fa5.1.A13-620
99.34
Assess
Isoform 3monomer0.905fa5.1.A13-576
99.29
Assess
Isoform 4monomer0.855fa5.1.A13-466
98.90
Assess
Isoform 5monomer0.915fa5.1.A13-593
100.00
Assess

Alignments